Sign in

Carole Madjo

Wall Street Analyst at Barclays PLC

Carole Madjo is a Wall Street Analyst at Barclays, specializing in coverage of general sectors with a notable focus on major publicly traded companies such as Compagnie Financière Richemont and Moncler. She maintains research coverage on a diverse portfolio of 15 stocks, and according to TipRanks, she has generated a 51.72% success rate with an average return of 3.1% per rating based on 174 ratings issued since 2019, positioning her at #3,558 among Wall Street analysts. Madjo has been with Barclays since at least 2019, contributing to the firm's analyst coverage teams after previous experience that is not publicly detailed. While her professional credentials and securities licenses are not listed on FINRA records or public disclosures, her active analyst role is reflected by her published research and ranking among industry peers.

Carole Madjo's questions to COMPAGNIE FINANCIERE RICHEMONT AG /FI (CFRUY) leadership

Question · Q4 2023

Carole Madjo from Barclays asked about increased competition for talent in the jewelry segment and the group's strategy for the Hainan market. She specifically inquired about Richemont's exposure, store opening plans, and how it mitigates risks like discounting and brand dilution in the region.

Answer

Van Cleef & Arpels CEO Nicolas Bos and CEO Jerome Lambert acknowledged healthy competition for talent but described the situation as balanced, highlighting Richemont's strength in attracting and developing skilled professionals. Regarding Hainan, Lambert stated it's an important tourist location but represents only a fraction of their China business. They operate with local partners and use numbered products to ensure qualitative distribution, expressing no major concerns about brand dilution or other risks.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts